Skip to content
Telehealth Graded

Search Telehealth Graded

Use arrow keys or Tab to browse. Enter opens a result. Escape closes search.

Enter a name or topic to search.

State guide

Michigan Medicaid and GLP-1s

Michigan took a different route from most of the states on this site. Medicaid still pays for GLP-1s prescribed for obesity, but from January 1, 2026 the bar moved, and the state's numbered letter to providers spells out exactly where it moved to.

Every source on this page was read first-hand in September 2026, and each one below carries the date printed on the document itself.

1
document cited
5
sourced facts
1
primary source

What changed, and what the document says

  1. Reduced, not removed

    Conditions apply

    The word the state uses is "reduced." Coverage survived; the criteria tightened.

    “Coverage of GLP-1 medications when prescribed solely to treat obesity, including requests for continuation, will be reduced.”

    Michigan Department of Health and Human Services, Program Policy Division — December 8, 2025

  2. The new bar

    Not covered

    Two conditions, both required: a morbid-obesity classification, and documented failure of everything else that was appropriate to try.

    “Patient must be classified as morbidly obese; and Coverage is contingent on documented failure of all other clinically appropriate weight-loss interventions (including a trial and failure of Preferred Drug List [PDL] preferred anti-obesity agents); and”

    Michigan Department of Health and Human Services, Program Policy Division — December 8, 2025

  3. The reason a prescription has to give

    Conditions apply

    Michigan frames the drug as an alternative to surgery. That framing is the criterion, not a comment.

    “Coverage must be considered only as a measure to avert the need for higher-cost bariatric surgery.”

    Michigan Department of Health and Human Services, Program Policy Division — December 8, 2025

  4. Everything else is untouched

    Covered

    Diabetes and the other approved uses carry on exactly as before.

    “Coverage of GLP-1 medications when requested for other existing indications other than to treat obesity will not be changing.”

    Michigan Department of Health and Human Services, Program Policy Division — December 8, 2025

  5. When it starts

    Context

    Dates of service from January 1, 2026.

    “Effective for Dates of Service On or After January 1, 2026:”

    Michigan Department of Health and Human Services, Program Policy Division — December 8, 2025

Telehealth in Michigan

Some providers pay us a commission when you sign up through our links, at no extra cost to you.

Which of these companies serve Michigan?

Of the 284 companies we grade, 28 publish a list of the states they are licensed in. We checked 250 more and found no such list on any page we read; 6 we have not checked either way.

21 of those lists name Michigan: Gala Health, Care Bare Rx, Vita Bella, TelePeptide, Levity, Wisp, WePeptideRx, Ways2Well, TeleClinic, Tyde Wellness, Willow, VevaRx, Trimi, Enhance MD, HumeCare+, Rx.com, Mojoon, Peak Wellness, Sprout Health, Allara Health, and MEDvidi. That is a licensure claim each company makes about itself, not something we checked with a state board.

A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.

Coverage decides what you pay before cash does. See how state Medicaid programs cover GLP-1s and what a prior-authorization denial turns on.

Sources

Each document below was fetched and read on the date shown beside it, which is the date printed on the document — not always the date in its web address. All of them were read in September 2026.

Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.